Regenxbio Inc (RGNX)
Debt-to-assets ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 573,970 | 633,786 | 682,458 | 747,830 | 833,268 | 883,793 | 953,444 | 1,025,370 | 1,113,900 | 800,395 | 836,402 | 879,442 | 708,164 | 541,174 | 449,738 | 463,936 | 497,908 | 509,237 | 529,139 | 519,031 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $573,970K
= 0.00
The debt-to-assets ratio for Regenxbio Inc has consistently remained at 0.00 for each quarter reported, including Q4 2023, Q3 2023, Q2 2023, Q1 2023, Q4 2022, Q3 2022, Q2 2022, and Q1 2022. This indicates that the company has not used any debt to finance its assets during these periods. A debt-to-assets ratio of 0.00 typically suggests that the company is entirely financed by equity rather than debt, which can be viewed positively by investors and creditors as it signifies lower financial risk and greater financial stability. However, it is important to consider the company's overall financial strategy and objectives when evaluating the significance of this ratio.
Peer comparison
Dec 31, 2023